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Despite the large number of studies on the impact of psychosocial factors on breast cancer progression, there is no certainty about
the contributing factors or processes involved. We investigated the relative impacts of socioeconomic, psychological, and
psychosocial factors on survival in breast cancer. A consecutive sample of 102 patients (participation 82%) under 72 years of age with
locoregional breast cancer completed validated questionnaires on coping with cancer, emotional expression (anger), perceived
available support, noncancer life stresses, and quality of life 3 4 months after diagnosis. Survival times were measured from the date
of diagnosis to the date of relapse and further to the date of death or date of last follow-up. Cumulative Cox regression analyses
were carried out. After controlling for biological prognostic factors, age, and baseline treatment, longer survival was predicted by a
long education and a minimising-related coping, while shorter survival was predicted by emotional defensiveness (antiemotionality),
behavioural-escape coping, and a high level of perceived support. A shorter event-free time was also predicted by unemployment
and depressive symptoms. Cancer survival is affected by a complex combination of psychosocial factors, among which minimising
predicts a favourable prognosis and anger nonexpression and escape behaviour an unfavourable prognosis. Higher socioeconomic
status is associated with longer survival. High scores in well-being scales may reflect emotional nonexpression.
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The impact of psychosocial factors on cancer progression has been
investigated in a number of studies (Greer et al, 1979, 1990;
Pettingale et al, 1985; Gross, 1989; Spiegel et al, 1989; Forsen,
1991; Barraclough et al, 1992; Blanchard et al, 1995; Maunsell et al,
1995; Dolbeaut et al, 1999; Watson et al, 1999; Butow et al, 2000;
Reynolds et al, 2000; Spiegel, 2001; Petticrew et al, 2002; Garssen,
2004) and many of these have dealt with breast cancer (Greer et al,
1979, 1990; Pettingale et al, 1985; Spiegel et al, 1989; Forsen, 1991;
Barraclough et al, 1992; Maunsell et al, 1995; Watson et al, 1999;
Butow et al, 2000; Reynolds et al, 2000; Garssen, 2004). However,
the contributing factors are uncertain, and there is also a lack of
understanding of the psychological processes and the psycho-
biological mechanisms involved (Garssen and Goodkin, 1999). In
many studies, the theoretical basis has been insufficient, the
psychological constructs investigated have varied study by study,
and there has been no agreement on definition, operationalisation,
and methodology (Butow et al, 1999; Garssen and Goodkin, 1999;
Reynolds et al, 2000; Garssen, 2004; Garssen and Remie, 2004).
This has made it difficult to summarise the results and has often
led to questionable comparisons of studies evaluating different
concepts. Many earlier studies have not controlled for biological
prognostic factors or considered socioeconomic status (Garssen
and Goodkin, 1999; Garssen and Remie, 2004). Furthermore, the
impact of a certain psychosocial factor or factors has often been
examined separately (Barraclough et al, 1992; Petticrew et al,
2002), while possible simultaneous effects have been neglected
(Garssen and Goodkin, 1999; Garssen, 2004; Garssen and Remie,
2004).
Current research suggests that the most important psychosocial
risk factors in cancer progression may include nonexpression of
negative emotions (Garssen and Goodkin, 1999; Reynolds et al,
2000; Garssen, 2004) and helplessness/depression (Watson et al,
1999), and that life stresses (stressful life events) and low levels of
social support may also have an effect (Maunsell et al, 1995;
Garssen and Goodkin, 1999; Garssen, 2004). Favourable prognoses
seem to be predicted by a response pattern of denying and/or
minimising the fact of having cancer (Butow et al, 1999, 2000;
Garssen, 2004). Classical findings concerning concepts like fighting
spirit, stoic acceptance, or fatalism (Greer et al, 1979; Pettingale
et al, 1985) have not been replicated in recent studies (Watson
et al, 1999; Petticrew et al, 2002; Garssen, 2004). Psychosocial
interventions are thought to have an effect on the mediating
psychosocial factors and the well-being and survival outcomes
(Fawzy et al, 1993; Dolbeaut et al, 1999; Fawzy, 1999). The most
important psychological factors and processes that influence the
psychobiological mechanisms must be identified in order to
pinpoint targets for comprehensive cancer care and psychosocial
interventions.
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sThe psychobiological mechanisms that affect cancer progression
are thought to be related to psychological stress (Kiecolt-Glaser
and Glaser, 1999). It has been suggested that the processes of
psychological stress include cancer and treatment as independent
factors, and that sociodemographic factors, coping, adaptation,
personality factors, medical factors, socio-environmental factors,
and life stresses are mediators and/or moderators of the processes
(Dolbeaut et al, 1999; Lehto et al, 2005). It is suggested that these
affect both quality of life (QOL) and survival. Coping can be seen as
the main mediator in the process from cancer and its treatment to
the health outcomes (Folkman et al, 1986a,b; Holahan and Moos,
1986; Folkman et al, 1991; Lazarus, 1993; Reynolds et al, 2000;
Petticrew et al, 2002), and social support and personality factors are
assumed to modify the process (Cobb, 1976; Cohen and Wills, 1985;
Holahan and Moos, 1986; Burgess, 1987; Temoshok, 1987; Folkman
et al, 1991; Blanchard et al, 1995). Also, the presence of other
(noncancer) life events at the time of the illness has an effect on the
cancer-related stress processes because patients often need to make
efforts in order to cope with them, and this may influence or
interfere with coping with cancer or affect the health outcomes
(Dolbeaut et al, 1999). We have recently presented a model of these
factors and their influence on cancer (Lehto et al, 2005), and applied
it for studying survival in localised melanoma (Lehto et al, 2006).
Personality influences coping processes (Greer and Watson,
1985; Temoshok, 1987; Gross, 1989; Dolbeaut et al, 1999). A
concept of Type C behaviour, a personality characteristic which
can tolerate less stress and is thus more vulnerable, is thought to
be associated with the progression of cancer (Greer and Watson,
1985; Burgess, 1987; Temoshok, 1987; Gross, 1989; Eysenck, 1994;
Garssen and Remie, 2004). The Type C response style is a
multidimensional construct which includes nonexpression of
negative emotions as a core element, to which are added the
dimensions of helplessness and hopelessness in stressful situations
and the element of being in behaviour in relation to other people
self-sacrificing, over-cooperative, sociable and appeasing, and
compliant with external authorities. Stressful situations may be
more threatening for people with Type C, because they cannot
allow themselves to express negative emotions. It has been claimed
that this contributes to less effective coping (Petticrew et al, 2002)
or a worse outcome. Also, the antiemotionality trait (emotional
defensiveness) is related to suppression and control of emotions
(Swan et al, 1992), and has been reported to have an unfavourable
effect on cancer progression (Grossarth-Maticek et al, 1985; van
der Ploeg et al, 1989). It refers to a tendency to avoid emotions
related to other people and to exhibit more anger control and less
anger expression, and is the opposite of Type A behaviour (Swan
et al, 1992). Antiemotionality trait is close to the concept of
personal defensiveness involved in the nonexpression of negative
emotions (Garssen and Remie, 2004) and it results in sociable and
appeasing behaviour. These are both included also in the Type C
style (Greer and Watson, 1985; Temoshok, 1987; Gross, 1989).
In accordance with our theoretical model (Lehto et al, 2005), we
assume that the biopsychosocial outcome in cancer is influenced by
coping with cancer, which is modified by social support, personality
factors, and noncancer life stress, and initiated by cancer-related
stressors. Here, we investigate the impact of psychosocial factors on
biological (survival) outcomes. Our aim is to investigate the impact
of the baseline (3–4 months from diagnosis) mediating psychosocial
factors: coping, social support (only perceived available support),
nonexpression of emotions (anger), noncancer life stresses, and
domains of QOL on survival in locoregional breast cancer.
MATERIALS AND METHODS
Patients
Newly diagnosed 30–70-year-old breast cancer patients with
localised or regional disease who were admitted for treatment
and/or follow-up to the Tampere University Hospital (Finland)
Oncology Clinic from January to October 1996 were consecutively
included, as described in detail in our previous work (Lehto-
Ja ¨rnstedt, 2000; Lehto et al, 2005). In situ breast cancers were
excluded. Two patients were excluded because of chronic
schizophrenia and consequent difficulty in understanding the
nature of their disease or treatment and two patients for having
had cancer previously, which was thought to have influenced the
psychological stress processes. The remainder was invited to
participate in the study, firstly by letter and later by personal
contact. In all, 82% (n¼102) of the patients invited participated.
After the exclusion of one male patient, the final study group for
the survival analyses consisted of 101 patients, of whom 33 had lymph
node metastases. Patients were treated according to national Finnish
guidelines for breast cancer treatment. Prior to the interview there
was no new antidepressive treatments, no visits to the outpatient
psychiatric clinic, and no hospitalisations for psychiatric reasons. The
disease and treatment variables of patients are detailed in Table 1, and
sociodemographic and socioeconomic variables in Table 2. At 15
February 2005, 31 patients had relapsed and 20 had died.
Procedure
The patients were interviewed 3–4 months after diagnosis
according to a specific structural format and by the same
Table 1 Disease and treatment variables in patients
Variable % (n¼102)
Tumour size (largest diameter)
Range 4–80mm, mean 17.4 (s.d. 11.7)
Stage
I5 4
II 39
III 4
Undetermined 2
Histologic type
Ductal carcinoma 72
Lobular carcinoma 20
Grade
13 9
23 2
31 6
Presence of hormone receptors
Oestrogen receptors 83
Progesterone receptors 67
Either 84
Metastases
None 66
Regional 32
Number of positive lymph nodes: range 1–15, mean
2.88 (s.d. 2.98)
Amount of positive lymph nodes out of the total:
range 0.1–1, mean 0.39 (s.d. 0.24)
Baseline surgery
Breast conserving 60
Mastectomy (simple or modified radical) 39
Baseline adjuvant treatment
Surgery only 28
+ Radiotherapy 72
+ Chemotherapy 24
+ Hormonal therapy 24
Presence of other chronic disease 44
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spsychologist (the first author). The interviewees completed several
structured validated questionnaires, indicating the presence,
frequency, or intensity of coping with cancer, emotional expres-
sion-related personality factors, perceived available support,
noncancer life stresses, and QOL.
Coping with cancer was measured with the Ways of Coping
Questionnaire (WOC) (Folkman and Lazarus, 1988; Lazarus, 1993),
developed ‘to identify the thoughts and actions an individual has
used to cope with a specific stressful encounter’ (here any aspect of
breast cancer) using an item structure proposed to form a WOC-
CA cancer-specific scale (Dunkel-Schetter et al, 1992; Stanton and
Snider, 1993) comprising the coping patterns Focusing on the
Positive, Distancing, Seeking and Using Social Support, Cognitive
Escape-Avoidance, and Behavioural Escape-Avoidance.
The patients’ evaluation of the social support which they
perceived would be available if needed was measured with the
MOS Social Support Survey (Sherbourne and Stewart, 1991; Aalto
et al, 1995), a 20-item scale for adult patients with chronic
conditions divided into perceived emotional/informational sup-
port, practical support, and love.
Traits of anger expression were measured with the Anger
Expression Scale (AX/Scale) (Spielberger et al, 1988; Spielberger
and Sydeman, 1994) (24 items) referring to ‘the extent that an
individual engages in aggressive behaviour when motivated by
angry feelings’ and tapping three dimensions: Anger-in (angry
feelings are experienced but held in, ‘repression’), Anger-out
(yare expressed in aggressive behaviour), and Anger Control (the
outward expression is controlled) (Spielberger et al, 1999).
Emotional expression was measured with Rational/Emotional
Defensiveness (R/ED) (Spielberger, 1988; Swan et al, 1992;
Fernandez-Ballesteros et al, 1997) and Need for Harmony (N/H)
(Fernandez-Ballesteros et al, 1998) Scales. In R/ED, rationality (R)
refers to the extent an individual uses reason and logic as a general
approach to coping with the environment (control of anxiety), and
emotional defensiveness (ED) (antiemotionality) the extent an
individual uses reason and logic to avoid emotions related to other
people (to overcome emotional feelings, control of anger).
Stressful life events were evaluated from the year preceding the
interview by the Life Experience Survey (LES) (Sarason et al, 1978).
The more persistent stressful conditions were evaluated by the
Chronic Strains Survey (CSS) (13 items, by authors) (Lehto-
Ja ¨rnstedt, 2000; Lehto et al, 2005).
The Rotterdam Symptom Checklist (RSCL) (deHaes et al, 1990)
was used to measure the patients’ symptoms (psychological and
physical) and their intensity and also perceived quality of life (a
single-item index). Depressive symptoms were measured with
a 10-item Depression Scale (DEPS) (Salokangas et al, 1996),
concerning the feelings and symptoms experienced during the
previous month and developed for screening of depression in
Finnish primary health care settings. The DEPS also includes one
item which evaluates hopelessness. Breast cancer-specific symp-
toms were evaluated with EORTC-breast 23.
Information on the disease and its treatment was collected from
hospital records. The ethical committee of Tampere University
Hospital approved the research protocol. The researcher was
bound by national (The Union of Finnish Psychologists) and
international (American Psychological Association) ethical codes
of psychology.
Statistical analysis
Survival was measured from the date of diagnosis (date of the
PAD) to the date of advancement of the disease (event-free
survival) or date of death (overall survival) or was censored at the
date of last follow-up (15 February 2005) for surviving patients.
Descriptive statistics, ANOVA, and Pearson’s correlation (r) were
used to describe the sample and regression analysis to investigate
the association between the predictive psychosocial factors. The
Cox proportional hazards regression model (Cox, 1972) was used
to determine the simultaneous contribution of the psychological
and psychosocial predictors of survival times controlled for age,
biological prognostic factors, and cancer treatment. The propor-
tional hazard assumption was tested (Schoenfeld, 1982) for specific
variables and globally.
RESULTS
Differences in the psychosocial variables
Chemotherapy was more common in younger patients (Po0.001).
Distancing coping was associated with higher age, higher self-
reported QOL, less symptoms (P-values o0.05), and operation as
the only treatment (P¼0.01). Seeking and using social support was
applied more by patients with lymph node metastases, chemo-
therapy, and any adjuvant treatment (P-values o0.05). Cognitive
Escape-Avoidance was associated with hormonal therapy and
lower self-reported QOL (P-values o0.05), and especially with
psychological (P¼0.004) and depressive symptoms (P¼0.001).
Behavioural Escape-Avoidance was associated with higher scores
in the Anger-in trait (Po0.05). The coping patterns did not vary
depending on socioeconomic status.
The scores in the perceived social support scales were otherwise
normally distributed, but 15% of patients in emotional/informa-
tional support, 33% in practical support, and 44% in love support
scored the maximum amount of available support (12% in total
score). There were no differences in these scales between disease
variables and treatment. The scores increased by family income
and amount of emotional/informational support decreased with
age (P-values o0.05). The patients with high or maximum
perceived support scores scored lower in the Anger-in trait
(in total scores P-values o0.05, in maximum score P¼0.001)
and tended to report a better QOL and less physical symptoms
(P-values o0.05).
The anger expression traits did not differ by age or disease and
treatment. Anger-out and Anger Control traits were associated
highly negatively (r¼ 0.58, Po0.001), as reported before
(Spielberger et al, 1988). Emotional defensiveness was positively
Table 2 Sociodemographic and socioeconomic variables in patients
Variable % (n¼102)
Age
Mean 54.2 (s.d. 8.45) years
Gender
Male 1
Female 99
Marital status
Single 12
Married or cohabiting 68
Divorced 15
Widowed 6
Level of education
Basic 31
Medium 31
College or higher 34
Not known 2
Employment status (baseline)
Employed 55
Unemployed 13
Housewife 1
Retired 31
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sassociated with Anger Control (r¼0.34, Po0.001) and negatively
with Anger-out ( 0.26, P¼0.01). The Rationality scale increased
with more education (Po0.05). Emotional defensiveness was
higher among the highly educated compared with the rest
(Po0.05).
The reported symptoms and QOL (RSCL) did not differ by
disease, treatment, or socioeconomic variables, except that patients
who were employed experienced less physical symptoms. Depres-
sive symptoms (DEPS) were less common in patients with a longer
education (Po0.05), but did not vary depending on disease or
treatment. Almost one-half (42%) of the patients reported hope-
lessness.
The only difference that even approached statistical significance
between the patients who died and those who were alive at the end
of the follow-up was that emotional defensiveness was higher
among the deceased (P¼0.063).
Predictors of survival and event-free time
In the Cox proportional hazards regression model, we used age,
nodus (number of metastatic lymph nodes/the examined), tumour
size (mm), Grade 3 in ductal carcinoma (yes/no), hormonal
receptors (yes/no), oestrogen receptors (yes/no), type of baseline
surgery (breast conserving/mastectomy), baseline adjuvant treat-
ments (radiotherapy, chemotherapy, hormonal therapy), level of
education (basic, medium, high), working status (no/yes), family
income, and domains of the mediating psychosocial factors, that is,
coping with cancer, perceived social support, anger expression,
emotional expression, noncancer life stress, and domains of QOL,
as dependent variables (as described above using various codings).
Predictors of overall survival were investigated step by step by
adding groups of potential prognostic factors; the models for
overall survival are detailed in Table 3. Firstly, the biological
variables were modelled alone (model 1 in Table 3), then the
cancer treatment was added (model 2). Next, we added socio-
economic factors (model 3), and, finally, the psychosocial ones
were added (models 4–7). The analyses were continued with only
the socioeconomic and psychosocial variables having an important
impact (Po0.1), therefore Tables 3, 4, and 5 include only these
variables.
After adjusting for age and biological prognostic factors,
chemotherapy and a high level of education (college or higher)
were found to be protective factors. Psychosocial risk factors
comprised emotional defensiveness
a (antiemotionality), Beha-
vioural Escape-Avoidance
b coping, and a high level (over 70 in
the range 0–80) of perceived social support (When perceived
support was applied as scale variables: MOS emotional/informa-
tional support was predictive at P¼0.056, practical support
P¼0.026, and love P¼0.055 (total score P¼0.020)), whereas
Distancing
c coping was a protective factor. In addition, the
depressive symptoms had a survival-decreasing effect (Po0.050)
before the coping patterns were added into the final models.
To further adjust for the severity of the breast cancer,
the variables in model 7 (Table 3) were investigated in patients
with no local metastases or chemotherapy (11 deaths), and
the effects were found to be about the same (Table 4). When
the variables were tested in patients with Gradus o3 only, the
Table 4 Baseline measures predicting survival in patients with no local
metastases
Cox regression
Haz. ratio zP 4|z|
Age 0.9240  1.37 0.170
Tumour size (mm) 0.9990 0.04 0.970
High education 0.0761  2.46 0.014
Emotional defensiveness 1.6904 2.67 0.008
Distancing 0.7843  1.50 0.135
Behavioral Escape-Avoidance 1.2840 1.83 0.068
Perceived support, high 7.4078 2.61 0.009
Haz. ratio¼Hazards ratio.
Table 3 Series of models of baseline measures predicting survival time
Cox regression
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6. Model 7.
Haz. ratio P Haz. ratio P Haz. ratio P Haz. ratio P Haz. ratio P Haz. ratio P Haz. ratio P
Age 0.9709 0.308 0.9515 0.123 0.9551 0.151 0.9434 0.098 0.9604 0.262 0.9641 0.322 0.9854 0.672
Nodus (number of +) 1.2083 0.012 1.2724 0.003 1.2501 0.005 1.5415 0.001 1.5626 0.000 1.6968 0.000 1.8133 0.000
Tumour size (mm) 0.9673 0.219 0.9759 0.374 0.9845 0.526 0.9966 0.881 1.0093 0.708 1.0121 0.674 0.9947 0.853
Grade 3 3.5582 0.017 4.7315 0.005 4.6396 0.004 1.5985 0.498 1.4057 0.618 1.1763 0.830 1.6883 0.581
Chemotherapy 0.3475 0.149 0.3848 0.171 0.1372 0.032 0.1237 0.020 0.0924 0.012 0.1036 0.014
High education 0.3305 0.082 0.1696 0.016 0.1527 0.008 0.0826 0.002 0.0836 0.003
Emotional defensiveness 1.3066 0.007 1.4627 0.003 1.5663 0.001 1.3722 0.021
Distancing 0.8483 0.109 0.7654 0.020 0.7820 0.034
Behavioural Escape-Avoidance 1.2923 0.016 1.3779 0.008
Perceived support, high
a 5.1911 0.009
aIn the total score of the MOS Survey, the highest 40% vs the rest. Haz. ratio¼Hazards ratio.
aEmotional defensiveness comprising, for example, items ‘If someone
deeply hurts my feelings, I still try to treat them reasonably and to
understand their behavioury’, ‘I try to understand people even if I do
not like themy’, If someone acts against my needs and desires, I still try
to understand him/hery’
bCoping pattern Behavioural Escape-Avoidance included, for example,
items: I generally avoided being with people; I tried to make myself feel
better by eating, drinking, smoking, using drugs, or medications; I took a
big chance or did something very risky to solve the problem; I took it out
on other peopley.
cCoping pattern Distancing included, for example, items: Tried to keep
my feelings from interfering . . .; Didn’t let it get to me, refused to think
about it; Made light of it, refused to get too serious; Went on as if it were
not happening; Tried to keep my feelings to myself; Looked for a silver
lining, looked on the bright sidey.
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seffects were similar except that Distancing showed a reduced
effect (P¼0.125).
When the variables were tested one-by-one with the biological
and treatment variables (univariate analyses), only emotional
defensiveness (P¼0.007) and Behavioural Escape-Avoidance
(P¼0.057) were significant alone, that is, Distancing coping and
level of perceived support were not significant when tested without
the emotional defensiveness factor.
When mutual associations between the significant predicting
variables were analysed with regression analysis, depressive
symptoms were predicted by a stronger Anger-in trait, lower level
of perceived emotional/informational support, presence of adju-
vant treatment, and lower education. The level of perceived
support was increased by lower Anger-in, working outside the
home, and a higher level of emotional defensiveness.
When event-free survival (time without relapse) was studied
(Table 5), younger age predicted a shorter event-free time
(Po0.1) along with the biological prognostic factors (nodus,
gradus 3). Longer event-free time was predicted by baseline
chemotherapy. The socioeconomic factors had an effect only in
combination with the psychosocial ones: a long education slightly
predicted a longer event-free time (ns), while being unemployed
predicted a shorter time without relapse (Po0.1). Unlike overall
survival, shorter event-free time was only slightly predicted
by emotional defensiveness (P¼0.1). When all the previous
variables were included in the model, depressive symptoms and
high perceived support tended to predict a shorter time without
relapse.
The test for the final models (in Tables 3–5) showed that the
proportional hazard assumption was not violated either for
specific variables or globally, showing that it holds for the chosen
models.
DISCUSSION
Multiple cumulative regression models were applied and the
biological prognostic factors were carefully adjusted to investigate
the mutual additional effects of treatment, socioeconomic factors,
and psychosocial factors on survival in locoregional breast cancer.
Along with chemotherapy, a long education and responding to
having cancer with distancing/minimising acted as protective
factors, while emotional defensiveness (antiemotionality), escape
coping, and a high level of perceived social support acted as risk
factors.
We chose to study patients with localised breast cancer firstly
because it has been suggested that early cancer is better for
studying the effects of psychosocial factors, and secondly, that
some cancer types, including breast cancer, are probably
influenced by psychosocial factors via the neuro-hormonal-
immunological pathway (Kiecolt-Glaser and Glaser, 1995, 1999;
Garssen, 2004). The variables were selected based on a large
amount of previous research and a theoretical model that we had
constructed earlier (Lehto et al, 2005). They were assessed with
validated quantitative methods with good psychometric properties
(Lehto-Ja ¨rnstedt, 2000). Earlier studies have rarely taken all
elements of psychological stress processes (Dolbeaut et al,
1999; Lehto et al, 2005) into account simultaneously (Barraclough
et al, 1992; Petticrew et al, 2002; Garssen, 2004; Lehto et al,
2006), and have usually neglected socioecomomic status (Garssen
and Goodkin, 1999). Centralised cancer care in Finland allowed
us to collect a representative sample with a good participation
rate. Ethnic differences, which could have influenced the
psychosocial processes, hardly existed in this population from
central Finland.
The strongest predictor of survival was local lymph node status,
as suggested, and chemotherapy was an effective treatment.
However, the effect of an important biological prognostic factor,
gradus 3, vanished when the psychosocial variables were included.
Two factors belonging to the multidimensional construct of
socioeconomic status (Anderson and Armstead, 1995; Kristenson
et al, 2004) predicted survival, that is, a long education predicted a
favourable prognosis and unemployment predicted a shorter time
without relapse. High socioeconomic status has been reported to
prolong survival in cancer (Karjalainen and Pukkala, 1990; Forsen,
1991; Woods et al, 2006) and its effects may be mediated
by psychobiological mechanisms related to stress physiology
(Kristenson et al, 2004); people with low socioeconomic status
may have more stressors and fewer resources to cope with them.
Emotional defensiveness/antiemotionality refers to a personality
trait to control, suppress, or repress negative emotions in
interpersonal relationships and it is one of the several concepts
addressing nonexpression of negative emotions. (In behavioural
medicine, ‘repression’ is often used as a synonym for nonexpres-
sion of negative emotions and the concept of consciousness is
generally not included in the definition, unlike the use of the term
in psychodynamic literature (Garssen and Remie, 2004)). These
concepts include a variety of psychiatric and psychological
constructs concerning defence mechanisms, repression, emotional
nonexpression, and social and personal defensiveness (Panago-
poulou et al, 2002; Garssen and Remie, 2004). Antiemotionality
may be closest to personal defensiveness, and it is also close to
the main domain of the cancer-prone Type C response style
(Temoshok, 1987; Garssen and Remie, 2004), which is described by
nonexpression of negative emotions, such as anger and fear
(Garssen and Remie, 2004). Emotional defensiveness has been
suggested as being a distinctive risk factor in cancer (Fernandez-
Ballesteros et al, 1997). However, its definition is not clear
(Garssen and Remie, 2004). In this study, the unfavourable effect of
emotional defensiveness was strong and persistent. This agrees
with previous findings on the favourable effect of more expression
and less suppression of emotions on breast cancer progression
(Reynolds et al, 2000) and the unfavourable effect of anti-
emotionality in cancers (Grossarth-Maticek et al, 1985; van der
Ploeg et al, 1989). Our scale evaluated control of anger in
particular (Swan et al, 1992), and we found it to be associated
with the Anger Control trait of the highly validated AX/Scale,
which was, however, not predictive on breast cancer survival
(In corresponding data concerning localised melanoma (Lehto
et al, 2006), we found Anger-in and Anger Control traits
to predicted worse survival.). In contrast to other findings,
Japanese male patients with dichotomously (yes/no) measured
rationality/antiemotionality have been found to have a reduced
risk of death from cancer (Terada et al, 2000; Hirokawa et al,
2004). This may be due to differences between the effects of
various levels of the trait, cultural differences, or differences
between genders or cancer sites.
Table 5 Baseline psychosocial measures predicting event-free time
Cox regression
Haz. ratio zP 4|z|
Age 0.9501  1.81 0.070
Local metastases (number of +) 1.5998 4.14 0.000
Tumour size (mm) 0.9852  0.77 0.439
Grade 3 1.3668 0.46 0.643
Chemotherapy 0.1103  3.00 0.003
High education 0.5154  1.43 0.153
Unemployment 2.7154 1.84 0.066
Emotional defensiveness 1.1304 1.66 0.098
Depressive symptoms 1.0674 1.84 0.066
Perceived support, high 2.1766 1.79 0.074
Haz. ratio¼Hazards ratio.
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sAs in previous research, we identified only one protective
psychological factor, a coping pattern Distancing, which is close to
minimising (see footnote c). Denying or minimising the fact of
having the cancer has long been suggested to be a predictor of a
favourable cancer prognosis (Greer et al, 1979, 1990; Butow et al,
1999; Watson et al, 1999; Butow et al, 2000; Petticrew et al, 2002;
Garssen, 2004; Lehto et al, 2006). Minimising the impact of the
diagnosis is milder and nowadays a more realistic form of denial
(Garssen, 2004). It refers to minimising the seriousness of a
medical condition (not the subsequent negative affect) (Garssen
and Remie, 2004). Minimising can either be an event-driven
response or reflect a habitual style of minimising unpleasant
events (Garssen and Remie, 2004). In recent studies (Butow et al,
1999, 2000; Brown et al, 2000), it has been found to be associated
with longer survival in advanced breast cancer and melanoma
(Butow et al, 1999, 2000).
Behavioural Escape-Avoidance, previously found to have harm-
ful effect on the psychosocial well-being of cancer patients (Trask
et al, 2001; Lehto et al, 2005), was also associated with reduced
survival (the pattern used here was, however, not identical to the
one used in our QOL study (Lehto et al, 2005)). This pattern
(footnote b) also included avoidance of other people, which may
tentatively lead to a low level of social support, which is suggested
to reduce survival (Maunsell et al, 1995), and to overeating,
smoking, and drinking, which may decrease survival purely via
physiological processes.
Depression has long been suspected as having an unfavourable
effect on cancer progression, but the findings have remained
contradictory (Kaplan and Reynolds, 1988; Garssen and Goodkin,
1999; Watson et al, 1999; Garssen, 2004). In our study, depressive
symptoms were predictive on overall survival only when emotional
defensiveness was controlled, but the coping patterns were not
taken into account. It has also earlier been suggested that the effect
of depression is nonindependent, that is, connected to that of the
other psychosocial factors, such as nonexpression of negative
emotions (Garssen and Goodkin, 1999) and helplessness/hope-
lessness.
The unfavourable effect of a high level of perceived support may
also be due to the nonexpression of negative emotions. Support
was not evaluated as the social support that was actually received
(Lehto-Ja ¨rnstedt et al, 2004) but as patients’ perceptions of the
support hypothetically available if needed (an intrapsychic
domain). High scores in this kind of support measure may be
related to over-reporting in well-being measures (In our corre-
sponding data on localised melanoma (Lehto et al, 2006), we found
over-positively reported QOL to be highly predictive of shorter
survival.) and reflect repression of negative affect (Garssen and
Remie, 2004; Myers and Derakshan, 2004). In line with a previous
study (Kornblith et al, 2001), a large proportion (15–44%) of our
patients reported the highest possible level of perceived support
in the MOS Survey. It is claimed that between 10 and 20% of
the population answer self-report scales on distress in an overly
positive fashion (Myers and Derakshan, 2004) because they avoid
negative affect, that is, they possess a repressive coping style and
thus report less distress compared with non-repressors. The over-
reporting of perceived support may reflect the under-recognition
of needs and feelings that is included in Type C behaviour.
Furthermore, without suggesting repression as explanation, it is
difficult to interpret why emotional defensiveness Table 3,
footnote a was associated with a high level of support. It has
been claimed that exclusive reliance on standard self-
report methods with global ratings is an unsatisfactory way of
eliciting information from repressors (Myers and Derakshan,
2004). Using measures that require specific answers instead
of global ratings may help to solve this problem. Although
the MOS Survey (Sherbourne and Stewart, 1991) is highly
validated and useful, it has, in this same sample, been only partly
associated with the cancer-specific support actually received
(Lehto-Ja ¨rnstedt et al, 2004). The current findings suggest that
this method may be insufficient for evaluating social support
in (breast) cancer.
The factors we found to affect survival may be interpreted to
reflect relatively stable personality-related characteristics. This
finding is most probably due to using a single baseline
measurement only (Segerstrom, 2003) instead of using repeated
measurement of psychosocial factors and thus it does not indicate
a greater importance of personality-related elements over psycho-
social and stress factors.
Our findings support the idea that emotional non-expres-
sion has an outstanding adverse effect and, on the other
hand, denial/minimising a favourable effect on cancer survival
(Garssen, 2004). We conclude that the psychological processes
affecting cancer survival comprise a combination of various
interacting elements and that socioeconomic factors are of
importance. Emotional nonexpression seems to be related to
various concepts that are suggested to affect cancer progression,
such as the Type C construct and depression. Also, the patients
with high emotional nonexpression or a repressive coping style
may over-report in global well-being scales. This offers an
explanation for the apparently astonishing findings that good
well-being predicts poorer survival. High scores in global
well-being measures may refer to an additional psychosocial
risk factor, which needs to be studied further and which may
require clinical attention in terms of screening, care or focused
intervention.
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